Metraipolis › archive › dc_4772fa7c9be0

Efficacy of MAO-B and COMT inhibitors on quality of life in patients with Parkinson's disease: a Bayesian network meta-analysis — Europe PMC PMID:41716552

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41716552
DOI
10.3389/fneur.2026.1753555
License (as archived)
solo-consultazione
Archived
2026-11-06T03:36:17.957Z
SHA-256 of the archived text
c8159d7d5fdbc238d93c77903eab059ef11a9aa73af3167703b19f7a744c3212
Stable URL of this page
https://metraipolis.com/documento/dc_4772fa7c9be0

How to cite

Efficacy of MAO-B and COMT inhibitors on quality of life in patients with Parkinson's disease: a Bayesian network meta-analysis — Europe PMC PMID:41716552 — Europe PMC (en), https://europepmc.org/article/MED/41716552 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4772fa7c9be0 (Metraipolis archive dc_4772fa7c9be0, sha256 c8159d7d5fdbc238d93c77903eab059ef11a9aa73af3167703b19f7a744c3212)
BibTeX
@misc{dc4772fa7c9be0,
  title = {Efficacy of MAO-B and COMT inhibitors on quality of life in patients with Parkinson's disease: a Bayesian network meta-analysis — Europe PMC PMID:41716552},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41716552},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4772fa7c9be0; sha256 c8159d7d5fdbc238d93c77903eab059ef11a9aa73af3167703b19f7a744c3212},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41716552. Agents can read the archived copy with the MCP tool read_document.